CCL19 and breast cancer: In the individual-patient BC-BM pair analysis, the expression levels of CCL19, CCL21, and ESR1 in BCBM were lower than those in primary BC (p < 0.001, p < 0.001, and p = 0.003, respectively) (Figure 1e).